Severinova S.K., Makarenko V.N., Kazinina
E.N.
Chair of Dentistry (Postgraduate Education Division)
SI “Crimea State Medical University named
after S. I. Georgievsky”
Biochemical parameters of mixed saliva
during endosseous implants installation
The usage of dental implants expanded
indications to restoration of teeth alignment defects with fixed implants,
which gives us possibility to perform balanced prosthetic repair without teeth
dissection. The material compatibility condition becomes the most primary
problem for implants and tooth prosthesis made from different alloys. This
article is related to optimization of the fixed implant-supported prostheses’
constructional materials’ choice.
53 persons were selected for carrying out of investigation. Besides 15
almost healthy persons (norm) were examined. The first group of 38 persons was
composed of those whom were made the prosthetic appliance with PFM prosthesis
based on cobalt-chrome alloy (Duceram). The second group of 15 persons was
composed of those patients whom were made the prosthetic appliance with the
usage of nonmetal ceramic dental prostheses. Prosthetic alignment was carried
out by two stage implant procedure using “U-Impl” endosteal titanium screw
implants with the further restoration using different permanent constructions.
Inside the investigated groups were segregated 2 subdivisions (19
persons in the first group and 8 persons in the second group), which were
everyday intramuscular injected in gluteus with 1 ml single-dose of the “Erbisolum”
immunomodifier and antioxidant. The duration of therapeutic course comprises of
10 days.
Antioxidant potency of mixed sali va was measured by the property of
biomaterial to inhibit oxidation-reduction rate of Fe(2+)-2,6 -
dichlorophenol-indophenol (DCPIP) system.
|
Table 1 |
1 |
2 |
3 |
4 |
5 |
6 |
|
Group of |
|
Term of investigation (months) |
|
|||
|
investigation |
|
|
|
|
|
|
|
First group (PFM |
|
|
|
|
|
|
|
prosthesis based on |
|
|
|
|
|
|
|
CCA), n=38. |
|
|
|
|
|
|
|
A - without usage |
0,03 7± |
0,045+ |
0,051+ |
0,047+ |
0,036+ |
0,034+ |
|
of Erbisolum, n=19 |
0,001 |
0,003 |
0,002 |
0,003 |
0,001 |
0,002 |
|
|
p>0,005 |
+36,4 |
+54,5 |
+42.4 |
+9,0 |
+3,0 |
|
|
|
p<0,001 |
p<0,001 |
p<0,001 |
p>0,05 |
p>0,05 |
|
 - with using of |
|
|
|
|
|
|
|
Erbisolum, n=19 |
0,036+ |
0,044+ |
0,042+ |
0,040+ |
0,035+ |
0,033+ |
|
|
0,002 |
0,004 |
0,001 |
0,003 |
0,002 |
0,004 |
|
|
p>0,05 |
+33,3 |
+27,2 |
+21,2 |
+6,0 |
0 |
|
|
|
p<0,01 |
p<0,05 |
p<0,05 |
p>0,05 |
p>0,05 |
|
Second group |
|
|
|
|
|
|
|
(nonmetal ceramic |
|
|
|
|
|
|
|
prosthesis), n = 15. |
|
|
|
|
|
|
|
A - without usage |
0,034+ |
0,043+ |
0,040+ |
0,036+' |
0,034+ |
0,034+ |
|
of Erbisolum, n=7 |
0,004 |
0,002 |
0,002 |
0,003 |
0,002 |
0,003 |
|
|
p>0,05 |
+30,3 |
+21,2 |
+9,0 |
+3,0 |
+3,0 |
|
|
|
p<0,01 |
p<0,05 |
p>0,05 |
p>0,05 |
p>0,01 |
|
 - with using of |
|
|
|
|
|
|
|
Erbisolum, n=8 |
0,036+ |
0,042+ |
0,035+ |
0,034+ |
0,033+ |
0,033+ |
|
|
0,003 |
0,002 |
0,004 |
0,002 |
0,003 |
0,002 |
|
|
p>0,05 |
+22,2 |
+6,0 |
+3,0 |
0 |
0 |
|
|
|
p<0,05 |
p>0,005 |
p>0,05 |
p>0,05 |
p>0,05 |
|
Control group |
0,033+ |
|
|
|
|
|
|
n = 15 |
0,002 |
|
|
|
|
|
Toward the first month of investigations after the prosthetic repair
changes were imperceptible and had imperceptible slight static attribute
(p>0,05) in relation to control group. Towards the second month of
investigations the cascade growth of mixed saliva enzymatic activity was marked
in all the investigated groups, but the most expressed growth was in the first
group, Table 1.
Toward the third month of investigations in the subdivision A of group 1
progressive growth of mixed saliva enzymatic activity was observable, which
activity in comparison with control group was increased on 54,5% (p<0,001),
at same time in the subdivision B, where “Erbisolum” immunomodifier was used,
was registered the tendency to decrease of mixed saliva enzymatic activity. In
the second group of patients, where were used nonmetal ceramic dental
prostheses, in the subdivision A enzymatic activity of the mixed saliva was
higher than benchmark on 21,2%
(p<0,05), and in the subdivision  where “Erbisolum” was included in the structure of
multimodality therapy the growth of AOA equaled 6% thus acquiring uncertain
character in relation to control. Toward the fourth month of investigations
antioxidant activity in the first group, especially in the A subdivision was on
the high level. The same time in the second group, both in A and  subdivisions mixed saliva enzymatic activity had the
slight static attribute (p>0,05).
Henceforth (5-6 month) levels of AOA both in the first and in the second
investigation groups converged to the
benchmark level.
In such a manner as the result of handled investigation it’s possible to
come to the conclusion that nonmetal ceramic dental prostheses are the most
comparable with titanium implants. Usage of “Erbisolum” immunomodifier and
antioxidant essentially improves adaptation of organism during the postsurgical
period and decreases the risk of complications’ development.